Human medicines
Quassia Similiaplex
"Pascoe Pharm. Präparate GmbH" as the holder of the registration as a homeopathic medicinal speciality of "Quassia Similiaplex drops" has informed its…
Edronax
The marketing authorization holder has informed its supplied customers in a letter dated July 25, 2017, that a test result within the scope of a…
Buerlecithin
The marketing authorization holder has informed its supplied customers in a letter dated July 04, 2017, that individual bottles filled with distilled…
Mucosolvan Lutschpastillen
The marketing authorization holder has informed its supplied customers in a letter dated June 21, 2017, that in the course of stability tests a trend…
Trobalt
The marketing authorization holder has informed its supplied customers in a letter dated 23.06.2017 that due to the global decision of the company,…
Elotrace
The marketing authorization holder has informed its supplied customers in a letter dated May 23, 2017, that increased black visible particles have…
Albiomin
The marketing authorization holder has informed its supplied customers in a letter dated April 27, 2017, that the affected batches are being recalled…
Extended recall of EpiPen 300 micrograms and EpiPen Junior 150 micrograms solution for injection in a prefilled pen (epinephrine)
EpiPen recall 2
The marketing authorization holder has informed its supplied customers about the extended voluntary recall of additional EpiPen batches in a letter…
Buerlecithin
The marketing authorization holder has informed its supplied customers in a letter dated April 6, 2017, that individual bottles filled with 100 ml of…
